2 studies found for:    18809614 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
2 Unknown  To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer
Conditions: Thoracic Neoplasms;   Non-small Cell Lung Cancer
Intervention: Radiation: 3D conform radiotherapy

Indicates status has not been verified in more than two years